Horm Metab Res 2009; 41(12): 909
DOI: 10.1055/s-0029-1243513

© Georg Thieme Verlag KG Stuttgart · New York


Further Information

Publication History

Publication Date:
04 December 2009 (online)

Table of Contents

Foley JE, Sreenan S. Efficacy and Safety Comparison Between the DPP-4 Inhibitor Vildagliptin and the Sulfonylurea Gliclazide After Two Years of Monotherapy in Drug-naïve Patients with Type 2 Diabetes. Horm Metab Res 2009; 41: 905–909

In the original article Figure 2 was incorrect. In the line graph, the baseline data (at week 0) for HbA1c were missing. The corrected figure is provided below. This mistake does not affect the remaining content of the article.

Zoom Image

This article is an erratum to 905 in: Journal of HMR, Issue 12, 2009 .

Zoom Image